These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33342090)

  • 1. Synthetic mRNA-based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells.
    Akiyama T; Sato S; Ko SBH; Sano O; Sato S; Saito M; Nagai H; Ko MSH; Iwata H
    Stem Cells Transl Med; 2021 Apr; 10(4):572-581. PubMed ID: 33342090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.
    Aflaki E; Stubblefield BK; McGlinchey RP; McMahon B; Ory DS; Sidransky E
    Neurobiol Dis; 2020 Feb; 134():104647. PubMed ID: 31669751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons.
    Xue Y; Zhan X; Sun S; Karuppagounder SS; Xia S; Dawson VL; Dawson TM; Laterra J; Zhang J; Ying M
    Stem Cells Transl Med; 2019 Feb; 8(2):112-123. PubMed ID: 30387318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.
    Suzuki S; Akamatsu W; Kisa F; Sone T; Ishikawa KI; Kuzumaki N; Katayama H; Miyawaki A; Hattori N; Okano H
    Biochem Biophys Res Commun; 2017 Jan; 483(1):88-93. PubMed ID: 28057485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of Parkinson's disease in type 1 Gaucher disease.
    Bultron G; Kacena K; Pearson D; Boxer M; Yang R; Sathe S; Pastores G; Mistry PK
    J Inherit Metab Dis; 2010 Apr; 33(2):167-73. PubMed ID: 20177787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Differentiation Potential of Gaucher's Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation.
    Awad O; Panicker LM; Deranieh RM; Srikanth MP; Brown RA; Voit A; Peesay T; Park TS; Zambidis ET; Feldman RA
    Stem Cell Reports; 2017 Dec; 9(6):1853-1867. PubMed ID: 29198828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1.
    Srikanth MP; Jones JW; Kane M; Awad O; Park TS; Zambidis ET; Feldman RA
    Stem Cells Transl Med; 2021 Jul; 10(7):1081-1094. PubMed ID: 33656802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy.
    Dubiela P; Szymańska-Rożek P; Eljaszewicz A; Lipiński P; Hasiński P; Giersz D; Walewska A; Tynecka M; Moniuszko M; Tylki-Szymańska A
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.
    Sison SL; Vermilyea SC; Emborg ME; Ebert AD
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):84. PubMed ID: 30284665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
    Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
    J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
    Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
    Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.
    Burbulla LF; Jeon S; Zheng J; Song P; Silverman RB; Krainc D
    Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining Parkinson's disease research using induced pluripotent stem cells.
    Pu J; Jiang H; Zhang B; Feng J
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):392-8. PubMed ID: 22622410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
    Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J
    J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease.
    Blauwendraat C; Tayebi N; Woo EG; Lopez G; Fierro L; Toffoli M; Limbachiya N; Hughes D; Pitz V; Patel D; Vitale D; Koretsky MJ; Hernandez D; Real R; Alcalay RN; Nalls MA; Morris HR; Schapira AHV; Balwani M; Sidransky E
    Mov Disord; 2023 May; 38(5):899-903. PubMed ID: 36869417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells into Dopaminergic Neurons.
    Daadi MM
    Methods Mol Biol; 2019; 1919():89-96. PubMed ID: 30656623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.